Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Earnings Announcements
Fusion Pharmaceuticals Q1 Loss Per Share $0.46
Published: 05/10/2022 11:15 GMT
Fusion Pharmaceuticals Inc (FUSN) - Q1 Loss per Share $0.46.
As of March 31, 2022, Fusion Held Cash, Cash Equivalents and Investments of $206.7 Million.
Q1 Earnings per Share View $-0.48 -- Refinitiv Ibes Data (analyst estimates).
As of March 31, 2022, Fusion Held Cash, Cash Equivalents and Investments of $206.7 Million.
Q1 Earnings per Share View $-0.48 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.18 Million
Adjusted EPS is expected to be -$0.51
Next Quarter Revenue Guidance is expected to be $0.17 Million
Next Quarter EPS Guidance is expected to be -$0.53
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.51
Next Quarter Revenue Guidance is expected to be $0.17 Million
Next Quarter EPS Guidance is expected to be -$0.53
More details on our Analysts Page.